Dr. Stephen Ellis on how iFR moves the ball forward
The key question is what happens long-term
Pioneer of angioplasty never stopped innovating and teaching
Meta-analysis proves its value, but patient risk defines its role
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Median treatment time trimmed to 52 minutes
A PI’s perspectives on ABSORB III interim results
Optimal timing still questioned
Despite DES, restenosis remains a risk
Enrollment continues in ABSORB trial comparing new scaffold to metallic drug-eluting stents